Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV-associated malignant lymphomas].

F Egli1, R Baumann, E Bernasconi

  • 1Departement für Innere Medizin, Universitätsspital Zürich.

Schweizerische Medizinische Wochenschrift
|April 4, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing the cost of capital to finance the energy transition in developing countries.

Nature energy·2024
Same author

SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.

HIV medicine·2024
Same author

Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.

HIV medicine·2021
Same author

Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

HIV medicine·2021
Same author

Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.

HIV medicine·2020
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

This study analyzed 35 HIV-infected patients with malignant lymphoma, finding CD4 count is the key survival predictor. While Hodgkin

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Context:

  • Malignant lymphomas are significant comorbidities in HIV-infected individuals.
  • Understanding prognostic factors is crucial for managing these complex cases.
  • Previous research suggests varying outcomes for different lymphoma subtypes in HIV patients.

Purpose:

  • To investigate the correlation between HIV disease stage, CD4 counts, and treatment modalities (antineoplastic agents, radiotherapy) with outcomes in HIV-infected lymphoma patients.
  • To compare the treatability and survival rates of Hodgkin's lymphoma (HL) versus non-Hodgkin's lymphoma (NHL) in the context of HIV infection.
  • To explore the potential association between HL and HIV infection.

Summary:

  • Retrospective analysis of 35 HIV-infected patients with malignant lymphoma (6 HL, 29 NHL).

Related Experiment Videos

  • Pretreatment CD4 count emerged as the most significant predictor of survival.
  • Median survival was 1.8 months for untreated and 5 months for treated patients. HL showed better treatability than NHL, but overall HL outcomes were less favorable than in non-HIV patients.

    • Impact:

    • Highlights the critical role of CD4 count in predicting survival for HIV-associated lymphomas.
    • Suggests that while HL might be more treatable than NHL in HIV patients, its overall prognosis remains poorer compared to non-HIV cases.
    • Underscores the need for further research into the potential link between HL and HIV infection due to observed higher proportions in the cohort.